MYND Life Sciences Announces Collaborative Research Agreement with the University of British Columbia Jan 12, 2022
MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application Dec 15, 2021
Study Shows Promise In Cure For Alzheimers: MYND Life Sciences Looks To Biomarkets In Fight Against Mental Disease Nov 23, 2021
MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and… Oct 27, 2021
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MYND Diagnostics Ltd. Oct 7, 2021
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering Sep 9, 2021
